108. Dwindling Exclusivity. Guest, Erika Lietzan.
Published August 11, 2017
35 min
    Add to queue
    Copy URL
    Show notes
    A deep dive into pharmaceutical patent protection and its intersection with the FDA new drug approval process. We touch on molecular drugs, biosimilars, data exclusivity, market exclusivity, the runway to generics, and fascinating differentials between different drug types or families. This is an intensely complex area and we were glad to have the benefit of a truly expert guide.
        0:00:00 / 0:00:00